loading
Schlusskurs vom Vortag:
$15.17
Offen:
$15.1
24-Stunden-Volumen:
12,975
Relative Volume:
0.27
Marktkapitalisierung:
$410.55M
Einnahmen:
$59,000
Nettoeinkommen (Verlust:
$-21.81M
KGV:
-1.4664
EPS:
-10.9518
Netto-Cashflow:
$-18.07M
1W Leistung:
+4.60%
1M Leistung:
+15.58%
6M Leistung:
+43.06%
1J Leistung:
+114.79%
1-Tages-Spanne:
Value
$15.10
$16.61
1-Wochen-Bereich:
Value
$15.02
$16.70
52-Wochen-Spanne:
Value
$5.742
$16.90

Benitec Biopharma Inc Stock (BNTC) Company Profile

Name
Firmenname
Benitec Biopharma Inc
Name
Telefon
(510) 780-0819
Name
Adresse
3940 TRUST WAY, HAYWARD, CA
Name
Mitarbeiter
16
Name
Twitter
@BenitecLtd
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
BNTC's Discussions on Twitter

Vergleichen Sie BNTC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
BNTC
Benitec Biopharma Inc
16.04 399.11M 59,000 -21.81M -18.07M -10.95
Biotechnology icon
ONC
Beone Medicines Ltd Adr
256.85 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
447.75 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.2213 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.31 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
497.31 65.36B 14.09B 4.50B 2.96B 39.28

Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-16 Eingeleitet H.C. Wainwright Buy
2024-12-13 Eingeleitet Robert W. Baird Outperform
2024-10-16 Eingeleitet Oppenheimer Outperform
2024-09-12 Eingeleitet Guggenheim Buy
2024-07-22 Eingeleitet Leerink Partners Outperform
2024-06-13 Eingeleitet Piper Sandler Overweight
2020-10-05 Herabstufung Ladenburg Thalmann Buy → Neutral
2020-04-20 Eingeleitet Ladenburg Thalmann Buy
2016-02-26 Herabstufung Maxim Group Buy → Hold
2015-12-31 Bestätigt Maxim Group Buy
2015-09-16 Bestätigt Maxim Group Buy
Alle ansehen

Benitec Biopharma Inc Aktie (BNTC) Neueste Nachrichten

pulisher
Jun 05, 2025

Wall Street Analysts See a 65.98% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? - Yahoo Finance

Jun 05, 2025
pulisher
Jun 05, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Position Boosted by Ameriprise Financial Inc. - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Jun 04, 2025
pulisher
Jun 02, 2025

Form 424B3 Benitec Biopharma Inc. - StreetInsider

Jun 02, 2025
pulisher
Jun 01, 2025

Northern Trust Corp Grows Stock Holdings in Benitec Biopharma Inc. (NASDAQ:BNTC) - Defense World

Jun 01, 2025
pulisher
May 29, 2025

Recent Price Trend in Benitec Biopharma (BNTC) is Your Friend, Here's Why - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 29, 2025
pulisher
May 27, 2025

Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise amid trials - Investing.com Nigeria

May 27, 2025
pulisher
May 27, 2025

(BNTC) Investment Report - news.stocktradersdaily.com

May 27, 2025
pulisher
May 23, 2025

Benitec Biopharma (BNTC) Files to Sell 900K Shares - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Benitec Biopharma (BNTC) Proposes Sale of 900K Common Shares | B - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Benitec Biopharma (BNTC) Proposes Sale of 900K Common Shares | BNTC Stock News - GuruFocus

May 23, 2025
pulisher
May 22, 2025

FY2025 EPS Forecast for Benitec Biopharma Raised by Analyst - Defense World

May 22, 2025
pulisher
May 20, 2025

Wall Street Analysts Think Benitec Biopharma (BNTC) Could Surge 83.91%: Read This Before Placing a Bet - Yahoo Finance

May 20, 2025
pulisher
May 20, 2025

Benitec Biopharma (NASDAQ:BNTC) Receives “Buy” Rating from HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

Benitec Biopharma (BNTC) Receives Buy Rating from HC Wainwright & Co. | BNTC Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Are Medical Stocks Lagging Benitec Biopharma (BNTC) This Year? - Yahoo Finance

May 19, 2025
pulisher
May 19, 2025

Leerink Partnrs Issues Optimistic Forecast for BNTC Earnings - Defense World

May 19, 2025
pulisher
May 17, 2025

Benitec Biopharma (NASDAQ:BNTC) Earns Market Outperform Rating from JMP Securities - Defense World

May 17, 2025
pulisher
May 16, 2025

(BNTC) Trading Signals - news.stocktradersdaily.com

May 16, 2025
pulisher
May 15, 2025

Benitec Biopharma (BNTC) Analyst Rating Update from JMP Securities | BNTC Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Benitec stock holds $20 target, Market Outperform rating - Investing.com

May 15, 2025
pulisher
May 15, 2025

Benitec stock holds $20 target, Market Outperform rating By Investing.com - Investing.com India

May 15, 2025
pulisher
May 14, 2025

Benitec (BNTC) Advances BB-301 Treatment for OPMD with Promising Clinical Progress | BNTC Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Benitec Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Benitec Biopharma Q3 Operating Income USD -10.2 Million - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Benitec Biopharma Releases Third Quarter 2025 Financial Results - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Benitec Biopharma reports Q3 EPS (24c) vs. (23c) last year - TipRanks

May 14, 2025
pulisher
May 14, 2025

Benitec Biopharma Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Benitec Biopharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Benitec Biopharma Releases Third Quarter 2025 Financial Results | BNTC Stock News - GuruFocus

May 14, 2025
pulisher
May 10, 2025

Benitec Biopharma (BNTC) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 06, 2025

How To Trade (BNTC) - news.stocktradersdaily.com

May 06, 2025
pulisher
May 05, 2025

Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance

May 05, 2025
pulisher
May 04, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

May 04, 2025
pulisher
May 02, 2025

Is Benitec Biopharma (BNTC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

May 02, 2025
pulisher
Apr 29, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Shares Purchased by Geode Capital Management LLC - Defense World

Apr 29, 2025
pulisher
Apr 26, 2025

Wall Street Analysts Believe Benitec Biopharma (BNTC) Could Rally 84.96%: Here's is How to Trade - MSN

Apr 26, 2025
pulisher
Apr 23, 2025

What Makes Benitec Biopharma (BNTC) a New Buy Stock - Yahoo Finance

Apr 23, 2025
pulisher
Apr 20, 2025

(BNTC) Long Term Investment Analysis - news.stocktradersdaily.com

Apr 20, 2025
pulisher
Apr 16, 2025

Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

Benitec Biopharma: An Under-The-Radar And Undervalued Gene Therapy Developer - Seeking Alpha

Apr 15, 2025
pulisher
Apr 12, 2025

JMP Securities Boosts Benitec Biopharma (NASDAQ:BNTC) Price Target to $20.00 - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Benitec Biopharma (BNTC) Stock Price Target Increased Amid Promi - GuruFocus

Apr 11, 2025
pulisher
Apr 10, 2025

Benitec stock price target raised to $20 at JMP Securities - Investing.com Australia

Apr 10, 2025
pulisher
Apr 10, 2025

Benitec stock price target raised to $20 at JMP Securities By Investing.com - Investing.com India

Apr 10, 2025

Finanzdaten der Benitec Biopharma Inc-Aktie (BNTC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Benitec Biopharma Inc-Aktie (BNTC) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
SUVRETTA CAPITAL MANAGEMENT, L
Director
Mar 26 '25
Buy
13.00
900,000
11,700,000
8,793,245
BUCHI J KEVIN
Director
Feb 27 '25
Option Exercise
3.86
51,813
199,998
103,910
SUVRETTA CAPITAL MANAGEMENT, L
Director
Dec 23 '24
Buy
10.98
27,502
301,972
7,981,725
SUVRETTA CAPITAL MANAGEMENT, L
Director
Dec 24 '24
Buy
11.25
20,018
225,202
7,999,455
SUVRETTA CAPITAL MANAGEMENT, L
Director
Dec 03 '24
Buy
9.60
42,000
403,200
7,957,365
SUVRETTA CAPITAL MANAGEMENT, L
Director
Nov 20 '24
Buy
10.22
27,436
280,396
7,920,175
SUVRETTA CAPITAL MANAGEMENT, L
Director
Nov 19 '24
Buy
9.73
14,000
136,220
7,895,815
$1.15
price up icon 1.30%
$584.68
price up icon 0.75%
$308.75
price up icon 1.19%
$37.33
price up icon 2.30%
$4.68
price down icon 3.35%
$492.00
price up icon 1.78%
Kapitalisierung:     |  Volumen (24h):